Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Alerg Mex ; 55(3): 92-102, 2008.
Article in Spanish | MEDLINE | ID: mdl-19058488

ABSTRACT

BACKGROUND: Anomalies in pulmonary function tests in obese are oriented predominantly to restrictive pathology, not been demonstrated efficiently. OBJECTIVE: To determine and compare pulmonary function tests (PFT) with anthropometric measurements by spirometry and plethysmograph in asthmatic obese (AO) and non-asthmatic obese (NAO) adolescents. PATIENTS AND METHOD: Cross-sectional study, with 86 adolescents. Obesity was defined as body mass index (BMI) greater to 95% percentile according to CDC and asthma, on the basis of the definition and criteria of GINA guidelines. Clinical history was made, doing anthropometric measures and PFT with determination of: forced vital capacity with maximal expiratory effort, forced expiratory volume in the first second, specific resistance and conductance. RESULTS: The average age was 12.68 years +/- 1.85, 39 were NAO and 47 AO, who had intermittent to persistent asthma, 14 patients received 200 mcg budesonide/day at least 4 weeks previous to the study. The average values in AO and their standard error for anthropometry were: weight: 68.5 +/- 13.6 kg, height: 154.58 +/- 9.1 cm, BMI: 28.27 +/- 3.24 kg/m2, abdominal circumference (AC): 98 +/- 8.85 cm and hip circumference (HC): 100 +/- 8.87 cm, in NAO: weight: 76.1 +/- 14.7 kg, height: 155.7 +/- 7.85 cm, BMI: 31.04 +/- 4.46 kg/m2, AC: 102 +/- 11.05 cm and HC: 103.28 +/- 10.6 cm. CONCLUSIONS: In NAO post-beta2 Raw diminished whereas Sgaw increased. Greater BMI in AO displayed greater FEV1 with statistic significance. Obstructive ventilator pattern mechanics was observed in both groups.


Subject(s)
Airway Resistance , Anthropometry , Asthma/physiopathology , Forced Expiratory Volume , Obesity/physiopathology , Vital Capacity , Adolescent , Adrenergic beta-Agonists/pharmacology , Adrenergic beta-Agonists/therapeutic use , Anti-Asthmatic Agents/pharmacology , Anti-Asthmatic Agents/therapeutic use , Asthma/complications , Asthma/drug therapy , Asthma/epidemiology , Body Height , Body Mass Index , Body Weight , Budesonide/therapeutic use , Child , Cross-Sectional Studies , Female , Humans , Male , Mexico/epidemiology , Obesity/complications , Obesity/epidemiology , Urban Population/statistics & numerical data , Waist Circumference , Waist-Hip Ratio
SELECTION OF CITATIONS
SEARCH DETAIL
...